About Wings Pharmaceuticals Pvt Ltd
Data last updated:
Wings Pharmaceuticals Pvt Ltd is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 April 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1987PTC027499. Its GSTIN is 07AAACW0963B1ZO (Delhi). The company holds 8 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹7.26 Cr and a paid-up capital of ₹1.8 Cr. It is led by directors including Varun Arora and Akshay Arora.
Its last annual general meeting (AGM) was held on 17 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 6 Udyog Nagar Indl. Area New Delhi, Delhi, India – 110041.
As per the financials filed for FY 2025, the company reported a revenue of ₹155.72 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹10.39 Cr (net margin 6.7%) and EBITDA of ₹15.95 Cr (EBITDA margin 10.2%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 18% over five years.
The company has about 339 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Wings Pharma. As per MCA filings, the company has open charges of ₹53.95 Cr and satisfied charges of ₹4.97 Cr on record. Court records list 229 cases involving the company, including 195 filed by the company and 33 filed against it; 46 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wingspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressD – 6 Udyog Nagar Indl. Area New Delhi, Delhi, India – 110041
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Wings Pharmaceuticals Pvt Ltd
The main business activity of Wings Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wings Pharmaceuticals Pvt Ltd FY 2025 filings available
Wings Pharmaceuticals Pvt Ltd reported revenue of ₹155.72 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Wings Pharmaceuticals Pvt Ltd
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 12% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wings Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.95 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.39 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wings Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wings Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jenburkt Pharmaceuticals Ltd Listed | ₹158.41 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Wardex Pharmaceuticals Private Limited | ₹158.1 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Chennai, Tamil Nadu, India |
| Nitin Lifesciences Limited | ₹157.19 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Paonta Sahib, Himachal Pradesh, India |
| Nu Sri Shyam Pharmaceuticals Private Limited | ₹156.54 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| New Amar Pharmaceuticals Private Limited | ₹156.03 Cr (FY 2024) | •••• | •••• | 46.0% | •••• | Pune, Maharashtra, India |
| Wings Pharmaceuticals Pvt Ltd this company | ₹155.72 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | New Delhi, Delhi, India |
| Jamp India Pharmaceuticals Private Limited | ₹155.09 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Ahmedabad, Gujarat, India |
| Combitic Global Caplet Private Limited | ₹154.55 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | New Delhi, Delhi, India |
| Medico Remedies Limited Listed | ₹153.63 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Sanzyme Private Limited | ₹153.25 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Hyderabad, Telangana, India |
| D K Pharma Chem Private Limited | ₹153.13 Cr (FY 2024) | •••• | •••• | -33.0% | •••• | Badlapur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Wings Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals Pvt Ltd is audited by Anil Jain DD & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Anil Jain DD & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varun Arora | Director | 28 Mar 2025 | 1 Years 6 Months | Current |
| Akshay Arora | Director | 28 Mar 2025 | 1 Years 6 Months | Current |
| Deepanshu Arora | Director | 31 Mar 2022 | 4 Years 6 Months | Current |
| Rajinder Prasad Arora | Director | 26 Mar 1991 | 35 Years 6 Months | Current |
Ownership and Shareholding of Wings Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wings Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2026 | Others | ₹10 Cr | Open |
| 19 Feb 2026 | Others | ₹16 Cr | Open |
| 06 Nov 2025 | Others | ₹3 Cr | Open |
| 06 Nov 2025 | Others | ₹3 Cr | Open |
| 06 Nov 2025 | Others | ₹3 Cr | Open |
Total charge records: 12 View all charges
Legal Cases of Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals Pvt Ltd has 229 court cases on record: 195 filed by Wings Pharmaceuticals, 33 filed against it, 1 where it is another party. 46 cases are pending and 183 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 171 | 14 | 36 |
| High courts | 56 | 17 | 9 |
| Supreme Court | 2 | 2 | 1 |
Cases on record (5 of 229)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Commercial suit | Filed by the company against Brinton Pharmaceuticals Limited | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against Igma Limited | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against Wingspan Pharmaceuticals Private Limited | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Khatri Healthcare Private Limited | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against Morvin India Health Care Private Limited | Disposed |
Full case history
All 229 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals operates one associated brand: Wings Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Wings Pharma distributes a wide range of pharmaceutical drugs. | wingspharma.com |
Employees and EPFO Compliance at Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals Pvt Ltd has a workforce of 339 employees as of Oct 10, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals Pvt Ltd has 7 board changes on record since 1991: 4 appointments and 3 cessations. The latest: Akshay Arora was appointed as Director on 28 Mar 2025.
14 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Wings Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wings Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wings Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals has 8 GST registrations: 3 active and 5 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACW0963B1ZO | Delhi | Active | 01 Jul 2017 |
| 07AAACW0963B2ZN | Delhi | Active | 23 Aug 2017 |
| 02AAACW0963B2ZX | Himachal Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wings Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wings Pharmaceuticals Pvt Ltd
Wings Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 April 1987 (39+ years old) and is registered under CIN U74899DL1987PTC027499.
Wings Pharmaceuticals reported revenue of ₹155.72 Cr for FY 2025 (up 12% YoY).
Wings Pharmaceuticals has 4 current directors:
- Varun Arora - Director
- Akshay Arora - Director
- Deepanshu Arora - Director
- Rajinder Prasad Arora - Director
Wings Pharmaceuticals reported a net profit of ₹10.39 Cr (net margin 6.7%) and EBITDA of ₹15.95 Cr (EBITDA margin 10.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wings Pharmaceuticals is 6% over three years and 18% over five years. In the latest year (FY 2025) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Wings Pharmaceuticals is 07AAACW0963B1ZO, registered in Delhi. The company has 8 GST registrations in all, of which 3 are active and 5 are cancelled or inactive. Other active GSTINs include 07AAACW0963B2ZN (Delhi), 02AAACW0963B2ZX (Himachal Pradesh).
The CIN (Corporate Identification Number) of Wings Pharmaceuticals is U74899DL1987PTC027499. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wings Pharmaceuticals has 229 court cases on record: 195 filed by the company and 33 filed against it. 46 are pending. Most are in the district courts.
Wings Pharmaceuticals was incorporated on 03 April 1987, making it 39+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Wings Pharmaceuticals by revenue are Jenburkt Pharmaceuticals Ltd, Wardex Pharmaceuticals Private Limited, Nitin Lifesciences Limited, Nu Sri Shyam Pharmaceuticals Private Limited, New Amar Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Akshay Arora was appointed as Director on 28 Mar 2025. Varun Arora was appointed as Director on 28 Mar 2025. Anil Arora ceased to be Director on 31 Mar 2022. Wings Pharmaceuticals has 7 board changes on record in total.